These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6788270)

  • 1. Antacids for duodenal ulcer.
    Murray JR
    Br Med J (Clin Res Ed); 1981 Jul; 283(6283):61. PubMed ID: 6788270
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.
    Bianchi Porro G; Lazzaroni M; Petrillo M; De Nicola C
    Lancet; 1984 Sep; 2(8404):698. PubMed ID: 6147723
    [No Abstract]   [Full Text] [Related]  

  • 3. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, radiological and laboratory findings in patients with duodenal ulcer, treated with micronized bismuth subnitrate, singly and in combination with antacids.
    Sezer R; Ozman M; Karaagac M
    Br J Clin Pract; 1975 Sep; 29(9):227-33. PubMed ID: 1191503
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind, endoscopically assessed evaluation of a bismuth subnitrate preparation (Roter) and cimetidine in the treatment of duodenal ulcer.
    Carr-Locke D; Wicks AB
    Br J Clin Pract; 1986 Sep; 40(9):373-5. PubMed ID: 3542004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on peptic ulcer therapy. 2. Ambulatory care of duodental ulcer using bismutum subnitricum].
    Berndt H; Gütz HJ; Jacobasch KH; Prahl B; Wolff G
    Dtsch Gesundheitsw; 1968 May; 23(20):913-6. PubMed ID: 4878481
    [No Abstract]   [Full Text] [Related]  

  • 9. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Nilacid treatment in ulcer.
    Figus AI; Papp I; Bajza Y
    Ther Hung; 1986; 34(1):54-6. PubMed ID: 2833824
    [No Abstract]   [Full Text] [Related]  

  • 12. Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
    Tytgat GN; Hameeteman W; van Olffen GH
    Clin Gastroenterol; 1984 May; 13(2):543-68. PubMed ID: 6378446
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of antacids in duodenal ulcer].
    Tsimmerman IaS; Golovanova ES; Syman LN
    Sov Med; 1985; (9):86-90. PubMed ID: 3906933
    [No Abstract]   [Full Text] [Related]  

  • 14. New perspectives in the treatment of peptic ulcer and related conditions.
    Milton-Thompson GJ; Misiewicz JJ
    Trans Med Soc Lond; 1977-1978; 94():46-57. PubMed ID: 317762
    [No Abstract]   [Full Text] [Related]  

  • 15. Bicitropeptide, antacid and placebo in gastric and duodenal ulceration. A two-centre, double-blind, comparative endoscopic study.
    Mekel RC; Serfontein WJ; Bank S; Barbezat GO; Novis BH
    S Afr Med J; 1979 Jan; 55(2):43-6. PubMed ID: 371034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with Bisuc in stomach diseases].
    Bartenschlager HM
    Z Allgemeinmed; 1973 Jun; 49(17):853-5. PubMed ID: 4580315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
    Gisbert JP; Boixeda D; Hernández Ranz F; Martín de Argila C
    Rev Esp Enferm Dig; 1995 Dec; 87(12):910-1. PubMed ID: 8562204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of the therapeutic effect of a herbazol preparation with and without an antacid component in duodenal peptic ulcer patients].
    Chakŭrski I
    Vutr Boles; 1984; 23(3):35-9. PubMed ID: 6380114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of duodenal ulcer.
    Misiewicz JJ
    Schweiz Med Wochenschr; 1979 Apr; 109(16):578-83. PubMed ID: 373101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of peptic ulcer.
    Misiewicz JJ
    Postgrad Med J; 1984 Nov; 60(709):751-9. PubMed ID: 6095240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.